Metadata
Author: Common crawl
Data
English[en]
Moleac, a bio-pharmaceutical company based in Singapore and with offices in France, has identified NeuroAiDTM and its potential to meet the needs of stroke survivors. Moleac is bringing NeuroAiDTM to western medicine internationally and ensures it meets western medicine standards to attend to the needs of stroke sufferers, supporting them to achieve better neurological and functional recovery.
Spanish[es]
Numerosos estudios han sido testeados sobre la eficacia para pacientes varios meses después de sufrir la apoplejía, y éstos han demostrado que los pacientes que tomaron NeuroAiDTM recuperan una mejor independencia.
French[fr]
Plusieurs études ont montré l'efficacité de NeuroAiDTM pour les phases tardive d'AVC (de 2 semaines à 6 mois après l'AVC), et ont montré que les patients qui prennent NeuroAiDTM ont davantage récupéré en indépendance, et plus rapidement.